Pfizer CEO Albert Bourla is expected at a pro-Trump fundraiser on Friday, sources told CBS News, one day after the president ...

Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.

Q2 2025 Earnings Call Transcript August 1, 2025 Ocugen, Inc. beats earnings expectations. Reported EPS is $-0.05, ...

He said if they didn't, the US would deploy 'every tool in our arsenal' to protect families from 'continued abusive drug ...

AstraZeneca already sells 40 per cent of its drugs to America and, following President Donald Trump 's tariff threat, is ...

Pfizer CEO Albert Bourla is expected to attend a $25 million fundraiser at US President Donald Trump’s golf club in ...

President Trump's latest trade salvo brought risk aversion back to the FTSE 100 index today as AstraZeneca fell sharply and ...

DONALD Trump insists he will unleash “every tool in our arsenal” if British drug companies don’t cut their prices within 60 ...

Pharmaceutical stocks across the global markets have taken a hit after Trump demanded drug companies lower prices for ...

While the Trump administration tries to pressure drug companies to lower prices, it has also spent months threatening tariffs ...

Bristol-Myers Squibb Company beats revenue forecasts & raises 2025 guidance. Click for key BMY catalysts, risks, and outlook ...

President Trump sent letters to major drug companies, urging them to lower U.S. medicine prices to match international rates.